Dade Behring

from Wikipedia, the free encyclopedia

Dade Behring was a NASDAQ- listed company active in the field of in vitro diagnostics . In 2006 global sales were $ 1.7 billion.

The company was founded in 1997 as a result of a merger between Dade International and the Behring Diagnostics unit of Hoechst AG . Previously, the diagnostics divisions of DuPont , Syva and Baxter Healthcare were combined in these companies . The company headquarters was in Deerfield near Chicago , with important production locations in Glasgow (Delaware) and Marburg . Well-known brand names of diagnostic devices are BCS, BN II, BEP III, BEP 2000, Quadriga BeFree, Dimension, MicroScan WalkAway and Dimension Vista.

The company consisted of the following product lines: chemistry / immunochemistry, hemostasis , microbiology , infection diagnostics, plasma protein diagnostics and Syva drug and drug diagnostics.

Up until 2006, the company developed new test methods such as CDT for monitoring alcohol abuse , homocysteine , a protein that indicates vitamin B12 / folic acid deficiency, ETP, a test method for endogenous thrombin potential, N / T Pro BNP, a new heart marker, and HIV Integral II, a particularly sensitive antigen / antibody combination test for the early detection of HIV infections, which is also suitable for screening blood banks due to its good sensitivity.

On July 25, 2007, Siemens AG announced the acquisition of Dade Behring for $ 7 billion in cash; the takeover was completed on November 6, 2007. Dade Behring was integrated into the Healthcare Sector as the Diagnostics Division .

Individual evidence

  1. ^ A b c d WORLD: Dade Behring: Siemens buys former Hoechst subsidiary . July 25, 2007 ( welt.de [accessed September 8, 2019]).
  2. ^ Dade Behring: US diagnostics company with German roots. In: Handelsblatt. July 25, 2007, accessed December 29, 2019 .
  3. ↑ Dade Behring in-licenses homocysteine ​​assay. In: The Pharmaletter. September 5, 2005, accessed December 29, 2019 .
  4. ↑ Patent DE102004059055A1 : Method for the automatic determination of the endogenous thrombin potential . Registered on December 7, 2004 , published on June 8, 2006 , inventors: Thilo Henckel, Andreas Weyl. ‌
  5. ↑ B. Cauliez: NT-proBNP measurement on Immulite 2500 (DPC): analytical performance and comparison with Roche Diagnostics and Dade-Behring NT-proBNP immunoassays. In: PubMed. 2007, accessed December 29, 2019 .
  6. ↑ HIV Assays: Operational Characteristics (Phase 1) Report 15 Antigen / Antibody ELISAs. (PDF) In: WHO. 2004, p. 23 , accessed December 29, 2019 .
  7. ^ Dade Behring is Siemens. Retrieved September 8, 2019 .